Results 171 to 180 of about 3,826 (203)
Some of the next articles are maybe not open access.
Fibrodysplasia Ossificans Progressiva
JCR: Journal of Clinical Rheumatology, 2021Carlos Enrique Suárez, Acosta +1 more
openaire +2 more sources
Myositis ossificans progressiva (Fibrodysplasia ossificans progressiva)
1967Unter den wechselnden Bezeichnungen fur die pathologische Verknocherung von Muskeln, Sehnen und Bandern verbirgt sich ein einheitliches Krankheitsbild, dessen erbliche Wurzel nicht zu ubersehen ist. Das Wesen der Erkrankung wird durch die gebrauchlichen Synonyma nur umschrieben: Myositis ossificans progressiva, Exostosis luxurians ...
openaire +1 more source
Fibrodysplasia ossificans progressiva in China
Bone, 2018Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare and devastating disorder characterized by cumulative episodes of progressive heterotopic ossification. It is estimated that there exist 600-700 patients in Mainland China. Nevertheless, due to the rarity, many FOP patients were initially misdiagnosed.
Dunmin, She, Keqin, Zhang
openaire +2 more sources
Integrative oncology: Addressing the global challenges of cancer prevention and treatment
Ca-A Cancer Journal for Clinicians, 2022Jun J Mao,, Msce +2 more
exaly
Fibrodysplasia ossificans progressiva.
European journal of dermatology : EJD, 2003Fibrodysplasia ossificans progressiva, a rare genetic disabling disease characterized by heterotopic bone formation, is of special interest for general medicine since the bone morphogenetic proteins (especially BMP-4) involved in its pathogenesis are known to play a role in skeletal morphogenesis, and the gene antagonist to BMP-4 noggin might be useful
Maria, Blaszczyk +3 more
openaire +1 more source
Fibrodysplasia ossificans progressiva
Der Anaesthesist, 2010T. Iber +3 more
openaire +2 more sources
Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma
Ca-A Cancer Journal for Clinicians, 2020Aaron J Grossberg +2 more
exaly
Oral complications of cancer and cancer therapy
Ca-A Cancer Journal for Clinicians, 2012Joel B Epstein +2 more
exaly

